Abbott LaboratoriesABT
NYSE · USA · Segment 6 of 8 in the Medicine, pharma & life science value chain: Diagnostics
In vitro diagnostics, medical devices that include the Libre glucose sensors, nutrition products and generic medicines: Abbott runs all four.
Diagnostics: Tests, imaging and assays that support clinical decision-making.
Key metrics
Market cap
$193B
Price
$116.67
Today
+0.0%
Return YTD
−6.9%
Return 1Y
−11.6%
P/E
35.5
P/S
4.1
P/B
3.8
Data as of 2026-08-25 · updates daily after U.S. close
Theme exposure
In the value chain
Supply chain
Supplies →
Same segment: Diagnostics
Compare ABT
See where Abbott Laboratories sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →